Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CN Stock MarketDetailed Quotes
Hunan Jingfeng Pharmaceutical (000908)
- 7.29
- +0.16+2.24%
Market Closed Apr 17 15:00 CST
12.83BMarket Cap81.91P/E (TTM)
7.39High7.04Low213.33KlotVolume7.10Open7.13Prev Close153.83MTurnover2.43%Turnover Ratio83.79P/E (Static)1.76BShares8.5752wk High347.14P/B6.41BFloat Cap3.1652wk Low7.49Limit Up879.77MShs Float19.51Historical High6.77Limit Down4.91%Range %0.49Historical Low--Dividend TTM7.21Avg Price82.72KlotAsk--Div Yield TTM100Lot Size125.60KlotBid
Hunan Jingfeng Pharmaceutical (000908) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -7.75%271.86M | -9.47%183.39M | -0.46%100.11M | -36.67%416.03M | -46.79%294.7M | -46.76%202.58M | -42.87%100.58M | -21.86%656.89M | -9.48%553.83M | -5.34%380.52M |
| Operating revenue | -7.75%271.86M | -9.47%183.39M | -0.46%100.11M | -36.67%416.03M | -46.79%294.7M | -46.76%202.58M | -42.87%100.58M | -21.86%656.89M | -9.48%553.83M | -5.34%380.52M |
| Other operating revenue | ---- | -79.36%974.37K | ---- | -58.87%4.76M | ---- | 27.21%4.72M | ---- | -36.02%11.58M | ---- | -39.63%3.71M |
| Total operating cost | -9.68%303.26M | -7.33%211.41M | 4.71%108.55M | -41.00%467.92M | -40.85%335.76M | -39.93%228.13M | -38.58%103.67M | -11.00%793.08M | -7.08%567.68M | -3.27%379.79M |
| Operating cost | -18.61%96.13M | -15.29%63.59M | -1.25%33.42M | -16.58%154.76M | -12.75%118.1M | -11.30%75.07M | -14.89%33.84M | -6.93%185.52M | -0.51%135.36M | -2.98%84.63M |
| Operating tax surcharges | 65.28%5.28M | 23.52%3.15M | 12.12%1.27M | -6.36%10.12M | -63.66%3.19M | -50.73%2.55M | -44.57%1.13M | -12.29%10.81M | -2.11%8.79M | -14.58%5.18M |
| Operating expense | 16.68%118.11M | 7.72%82.71M | 22.84%44.76M | -60.52%137.03M | -63.09%101.23M | -59.45%76.78M | -56.85%36.44M | -17.74%347.05M | -9.33%274.23M | -4.43%189.34M |
| Administration expense | -25.74%58.37M | -16.60%42.66M | -2.91%20.26M | -27.96%112.7M | -27.05%78.6M | -28.48%51.15M | -25.18%20.87M | -8.33%156.44M | 1.15%107.74M | 7.92%71.52M |
| Financial expense | -32.38%17.64M | -20.65%14.3M | -30.50%6.57M | -1.16%40.28M | -5.12%26.08M | -4.90%18.02M | -0.90%9.46M | -20.55%40.76M | -26.77%27.49M | -23.79%18.95M |
| -Interest expense (Financial expense) | -44.44%14.2M | -19.10%14.2M | -16.01%6.43M | -3.70%40.34M | -10.55%25.55M | -6.83%17.55M | -20.69%7.65M | -20.06%41.89M | -24.48%28.56M | -25.30%18.83M |
| -Interest Income (Financial expense) | -147.95%-153.81K | -1,343.76%-153.81K | 37.02%-68K | 92.58%-89.59K | 94.33%-62.03K | 98.09%-10.65K | 51.97%-107.96K | -7.73%-1.21M | -41.82%-1.09M | -31.13%-556.55K |
| Research and development | -9.62%7.74M | 9.69%5.01M | 17.09%2.26M | -75.21%13.02M | -39.16%8.56M | -55.09%4.57M | -62.15%1.93M | 47.31%52.51M | -27.50%14.07M | 0.91%10.18M |
| Credit Impairment Loss | -109.46%-653.42K | -111.83%-681.89K | -129.75%-1.62M | 102.14%6.96M | 387.40%6.91M | 49.40%5.77M | 55.08%5.44M | 127.23%3.44M | -50.56%1.42M | 96.10%3.86M |
| Asset Impairment Loss | 148.76%503.55K | 105.50%222.31K | --220K | 79.72%-19.2M | -2,082.60%-1.03M | -357.90%-4.04M | ---- | -109.09%-94.67M | -98.90%52.09K | -71.60%1.57M |
| Other net revenue | -43.62%6.78M | -53.07%2.79M | -90.31%796.77K | 796.42%255.75M | 3.21%12.02M | -57.15%5.94M | 125.64%8.23M | -105.77%-36.72M | -42.49%11.65M | -19.60%13.86M |
| Fair value change income | ---- | ---- | ---- | -105.05%-1.25M | ---- | ---- | ---- | 38.54%24.81M | ---- | ---- |
| Invest income | 423.00%1.4M | 8.16%-384.83K | 63.03%-10.24K | 6,353.09%264.31M | 41.33%-432.13K | 42.79%-419.01K | -20.42%-27.68K | 200.15%4.1M | 42.33%-736.55K | 39.26%-732.37K |
| -Including: Investment income associates | 9.50%-384.83K | 8.16%-384.83K | 63.03%-10.24K | -47.88%-1.94M | 42.27%-425.23K | 42.79%-419.01K | 32.99%-27.68K | 67.84%-1.31M | 42.33%-736.55K | 39.26%-732.37K |
| Asset deal income | -255.63%-211.05K | -221.77%-157.86K | 85.57%278.78K | -144.48%-3.36M | 136.13%135.61K | 121.88%129.63K | 136.12%150.23K | -22.84%7.56M | -14.33%-375.35K | -84.23%-592.33K |
| Other revenue | -10.84%5.74M | -15.91%3.79M | -27.57%1.93M | -54.00%8.3M | -42.94%6.44M | -53.81%4.51M | 363.96%2.66M | 9.63%18.04M | -20.88%11.29M | -13.48%9.76M |
| Operating profit | 15.20%-24.62M | -28.65%-25.24M | -248.78%-7.64M | 217.91%203.87M | -1,223.22%-29.03M | -234.45%-19.62M | -53.01%5.13M | -153.10%-172.91M | -110.38%-2.19M | -45.21%14.59M |
| Add:Non operating Income | -60.98%565.18K | 311.53%457.72K | 162.92%274.21K | -85.16%1.53M | 315.06%1.45M | -29.28%111.23K | 48.01%104.3K | 1,171.36%10.28M | 10.76%348.97K | 176.74%157.28K |
| Less:Non operating expense | -21.07%17.27M | -38.13%6.29M | -31.11%3.32M | 27.74%40.87M | -31.61%21.88M | 110.34%10.16M | 1,406.31%4.81M | 76.54%32M | 209.24%32M | -43.77%4.83M |
| Add:Adjusted items effecting total profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---160.78M | ---- |
| Total profit | 16.46%-41.33M | -4.72%-31.06M | -2,608.01%-10.68M | 184.54%164.53M | 74.58%-49.47M | -399.13%-29.66M | -96.01%425.78K | -127.28%-194.62M | -1,850.82%-194.62M | -45.20%9.92M |
| Less:Income tax cost | 2,643.47%1.95M | 182.01%1.12M | 828.97%500.97K | -84.53%5.08M | -99.78%71.03K | -90.82%396.64K | -97.21%53.93K | 241.23%32.84M | 187.03%32.84M | -27.20%4.32M |
| Net profit | 12.64%-43.28M | -7.06%-32.18M | -3,106.45%-11.18M | 170.10%159.45M | 78.22%-49.54M | -637.30%-30.06M | -95.75%371.86K | -138.79%-227.46M | -70,188.39%-227.46M | -53.99%5.59M |
| Net profit from continuing operation | 12.64%-43.28M | -7.06%-32.18M | -3,106.45%-11.18M | 160.91%159.45M | 81.08%-49.54M | -637.30%-30.06M | -95.75%371.86K | -74.17%-261.77M | -80,792.39%-261.77M | -53.99%5.59M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -37.65%34.32M | --34.32M | ---- |
| Less:Minority Profit | 279.29%1.29M | -87.13%384.83K | -51.83%719.89K | -17.36%7.14M | -108.32%-719.27K | -83.78%2.99M | -79.98%1.49M | -68.35%8.64M | -70.33%8.64M | -21.93%18.44M |
| Net profit of parent company owners | 8.71%-44.56M | 1.47%-32.57M | -960.04%-11.9M | 164.51%152.3M | 79.32%-48.82M | -157.30%-33.05M | -187.79%-1.12M | -92.64%-236.1M | -701.52%-236.1M | -12.07%-12.85M |
| Earning per share | ||||||||||
| Basic earning per share | 8.65%-0.0507 | 1.60%-0.037 | -938.46%-0.0135 | 164.49%0.1731 | -37.72%-0.0555 | -157.53%-0.0376 | -186.67%-0.0013 | -92.68%-0.2684 | -20.30%-0.0403 | -12.31%-0.0146 |
| Diluted earning per share | 8.65%-0.0507 | 1.60%-0.037 | -938.46%-0.0135 | 164.49%0.1731 | -37.72%-0.0555 | -157.53%-0.0376 | -186.67%-0.0013 | -92.68%-0.2684 | -20.30%-0.0403 | -12.31%-0.0146 |
| Other composite income | -11.31%130.83K | 233.14%47.03K | -52.55%16.1K | -105.12%-112.49K | -93.29%147.52K | -104.65%-35.32K | 105.64%33.92K | 295.38%2.2M | 1,130.84%2.2M | 35.48%758.88K |
| Other composite income of parent company owners | -11.31%66.72K | 233.14%23.99K | -52.55%8.21K | -106.65%-57.37K | -91.28%75.23K | -104.65%-18.02K | 105.64%17.3K | 237.02%862.92K | 847.73%862.92K | 35.48%387.03K |
| Other composite income of minority owners | -11.31%64.11K | 233.14%23.04K | -52.55%7.89K | -104.13%-55.12K | -94.58%72.28K | -104.65%-17.31K | 105.64%16.62K | 369.66%1.33M | 1,425.50%1.33M | 35.48%371.85K |
| Total composite income | 12.65%-43.14M | -6.78%-32.14M | -2,851.13%-11.16M | 170.73%159.33M | 78.07%-49.39M | -573.68%-30.1M | -95.02%405.78K | -133.72%-225.26M | -155,171.75%-225.26M | -50.05%6.35M |
| Total composite income of parent company owners | 8.71%-44.5M | 1.59%-32.54M | -975.89%-11.89M | 164.72%152.25M | 79.28%-48.74M | -165.44%-33.07M | -213.70%-1.11M | -90.95%-235.24M | -701.07%-235.24M | -11.47%-12.46M |
| Total composite income of minority owners | 309.23%1.35M | -86.28%407.88K | -51.84%727.78K | -28.97%7.09M | -103.01%-646.98K | -84.19%2.97M | -78.93%1.51M | -62.79%9.98M | -26.56%21.46M | -21.27%18.81M |
| Add:Adjusted items effecting total composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---11.48M | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Adverse Opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm